Benefits
Anticoagulant polysaccharide antithrombin-mediated
An acidic polysaccharide isolated via alkali extraction has the highest anticoagulant activity, with specific activity of 2 IU/mg and a molecular mass of ~160 kDa. Mechanism: thrombin inhibition catalyzed by antithrombin (not heparin cofactor II), with no Factor Xa antithrombin catalysis, so it is selectively thrombin-targeted. A distinguishing mechanism among mushroom polysaccharides.
Glucuronic acid carboxyl groups essential to activity
Activity disappeared after carboxyl reduction, establishing glucuronic acid carboxyl groups as essential to the anticoagulant mechanism. Polysaccharide composition: mannose + glucose + glucuronic acid + xylose with no sulfate esters, distinguishing it from heparin's sulfate-ester-driven mechanism.
Cholesterol-lowering polyphenolic + polysaccharide
Rats on a high-cholesterol diet remained healthier when given wood ear extract. Polyphenolic compounds were responsible (alone or together with polysaccharides), whereas earlier studies attributed the effect to polysaccharides only. Dual-mechanism cardiovascular profile beyond the anticoagulant activity.
Laboratory anticoagulant polysaccharide activity (in vitro + rats)
Wood ear polysaccharides showed aspirin-like anticoagulant effects in vitro and in rat models. Mechanism is distinct from aspirin's cyclooxygenase inhibition — these remain laboratory and animal findings and have not been shown to produce a comparable anticoagulant effect in people.
Early laboratory (cell-line) research only
Early laboratory studies have examined the polysaccharide in cultured cells. This is preliminary in-vitro research only, has not been tested in animals or people, and is not evidence that wood ear affects cancer or any disease.
Research context only: not a consumer benefit
The selective thrombin-only mechanism (vs heparin's broader Factor Xa + thrombin) is the conceptual basis for a potentially safer alternative to heparin, whose bleeding complication risk motivated the research. This research direction has not progressed to clinical heparin replacement.
Edible mushroom culinary integration
Extensive Asian culinary use record (Chinese, Korean, Vietnamese, Japanese cuisine) supports food-based safety. Traditional gastrointestinal-soothing uses; supplement-grade anticoagulant activity warrants different safety considerations than dietary consumption.
Mechanism of action
Antithrombin-catalyzed thrombin inhibition
The polysaccharide enhances antithrombin's thrombin-inhibiting activity — selectively targeting thrombin without enhancing antithrombin's Factor Xa inhibition. Distinct from heparin's broader effect on both thrombin and Factor Xa.
Glucuronic acid carboxyl groups essential
Carboxyl reduction abolished anticoagulant activity — establishing glucuronic acid carboxyl groups as the structural feature responsible for antithrombin enhancement. Different mechanism from heparin's sulfate-ester-driven activity.
Polyphenolic cholesterol lowering
Polyphenolic compounds drive cholesterol-lowering activity in animal models — possibly via bile acid binding, HMG-CoA reductase modulation, or LDL receptor effects. Mechanism details remain under investigation.
Preliminary cell-culture polysaccharide research
Preliminary observations in two cultured cell lines only. The polysaccharide has not been tested in animals or people for any cancer or disease outcome, and any immune-pathway mechanism is speculative.
Mannose + glucose + glucuronic acid + xylose composition
Polysaccharide composition: mannose, glucose, glucuronic acid, and xylose with NO sulfate esters. Distinguishing chemistry from heparin (sulfated glycosaminoglycan) and many other mushroom polysaccharides.
Anti-glycolipidemic activity
Polysaccharides also show anti-glycolipidemic activity, indicating complementary cardiovascular and metabolic effects beyond the anticoagulant action.
Clinical trials
Preclinical laboratory evidence (in vitro and rat studies) on Auricularia auricula-judae; no human clinical trials have evaluated these outcomes.
Preclinical model (in vitro and/or laboratory animals); not a human clinical population.
Yoon SJ et al. 2003 (Thromb Res). Acidic polysaccharide isolated via alkali extraction with highest anticoagulant activity. Specific anticoagulant activity 2 IU/mg, ~160 kDa molecular mass. Composition: mannose + glucose + glucuronic acid + xylose, NO sulfate esters. Mechanism: thrombin inhibition catalyzed by antithrombin (not heparin cofactor II); glucuronic acid carboxyl groups essential. Foundational mechanism characterization.
Rats on a high-cholesterol diet remained healthier with wood ear extract.
Preclinical model (in vitro and/or laboratory animals); not a human clinical population.
Rats on a high-cholesterol diet remained healthier with wood ear extract. Polyphenolic compounds responsible (alone or with polysaccharides) — earlier studies had attributed the effect to polysaccharides only. Animal cardiovascular protection evidence; human translation not established.
Documented in vitro anticancer activity in two cancer cell lines.
Preclinical model (in vitro and/or laboratory animals); not a human clinical population.
Documented in vitro anticancer activity in two cancer cell lines. Preliminary cell-line evidence; not advanced to animal cancer models or human trials.